Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells

MLA

Kjetil Taskén, et al. “Interleukin-33 Drives a Proinflammatory Endothelial Activation That Selectively Targets Nonquiescent Cells.” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 2, Nov. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a7f3fed1544abc8e068c2b9e896e822c&authtype=sso&custid=ns315887.

APA

Kjetil Taskén, Junbai Wang, Johanna Bodin, Eirik Sundlisæter, Monika Kasprzycka, Reidunn J Edelmann, Mari Johanna Brox, Olav Sundnes, Axel M. Küchler, Sigrid S. Skånland, Morten H. Vatn, Tamara Loos, Johanna Hol, Jon Sponheim, Jürgen Pollheimer, & Guttorm Haraldsen. (2012). Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(2).

Chicago

Kjetil Taskén, Junbai Wang, Johanna Bodin, Eirik Sundlisæter, Monika Kasprzycka, Reidunn J Edelmann, Mari Johanna Brox, et al. 2012. “Interleukin-33 Drives a Proinflammatory Endothelial Activation That Selectively Targets Nonquiescent Cells.” Arteriosclerosis, Thrombosis, and Vascular Biology 33 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a7f3fed1544abc8e068c2b9e896e822c&authtype=sso&custid=ns315887.